1. Heavy alcohol use or any other specific cause was not found in 38.0% of non-B non-C hepatocellular carcinoma (NBNC HCC) patients.
2. These NBNC-NA-NO (non-alcohol no-other identifiable cause) HCC group showed the highest proportion of non-cirrhotic patients (40.0%) and the lowest proportion of diagnosis under regular surveillance (18.8%).
3. Prior hepatitis B virus infection and metabolic risk factors may be major causes of HCC in NBNC-NA-NO patients.
1. Hepatic venous pressure gradient (HVPG) and liver stiffness (LS) can be combined to predict the mortality of patients with cirrhosis. Concurrent elevation of HVPG and LS showed the highest long-term mortality rates in patients with cirrhosis.
2. However, when either HVPG or LS alone was elevated, mortality did not increase significantly.
1. The persistence rate was significantly higher with non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) than with VKAs in a contemporary prospective, multicenter Korean atrial fibrillation registry.
2. There was no difference in the persistence rate among different NOACs in the maintenance group. However, apixaban or edoxaban showed a higher persistence rate than rivaroxaban in the new-starter group.